New Products

NEW YORK — Cefaly Technology announced Wednesday that the Cefaly medical device for the preventive treatment of migraine headaches is available for purchase and delivery in the United States for patients with a medical prescription at Cefaly.us.

The company that manufactures Cefaly expects to make the device available via select pharmacies and clinics in the months ahead. 

SOUTH DEERFIELD, Mass. — The Yankee Candle Co. announced the launch of Dream Garden, a limited-edition collection of garden fragrances. The line was inspired by the garden parties and consists of three fragrances: Garden Time, Blue Lavender and Sweet Pink.

Garden Time evokes the scent of fresh garden herbs; Blue Lavender mimics the scent of fresh lavender sprigs; and Sweet Pink contains a blend of sweet floral nectars.

WHIPPANY, N.J. — Bayer HealthCare on Tuesday announced that the Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for Bayer's investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis. Patients with NCFB suffer from frequent severe acute pulmonary bacterial exacerbations, which lead to further inflammation, airway and lung parenchyma damage.

PLANO, Texas — PepsiCo on Tuesday announced the debut of new Twistos Baked Snack Bites to its portfolio. The bites are available in three flavors — bruschetta, parmesan and garlic, and asiago flavors — and can be enjoyed as a standalone snackng item, or as complement to a soup or salad, the company said.

The brand has teamed up with chef and food writer Gaby Dalkin of "What's Gaby Cooking" to help develop tips for mixing up snack time.

RONKONKOMA, N.Y. — NBTY, a global manufacturer and distributor or vitamins and nutritional supplements, introduced Nature's Origin, the company's first complete line of vitamins, minerals and herbal supplements. The products are available in the United States direct to consumers at NaturesOrigin.com.

INDIANAPOLIS — Eli Lilly on Monday announced that the Food and Drug Administration has approved Cyramza (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. With this approval, Cyramza becomes the first FDA-approved treatment for patients in this setting.

HACKETTSTOWN, N.J. — Mars Chocolate last week announced the introduction of the M-Ball, a peanut M&M's-shaped twist on the traditional soccer ball. The vibrant ball started making the rounds in the United States on April 15, and it comes at a time when soccer fandom is reaching an all-time high, the company said.

SCOTTSDALE, Ariz. — Henkel’s Dry Idea brand has introduced its new Dry Idea Stain Clear.

The new invisible solid goes on clear and combines stain fighting technology with wetness protection and 72-hour odor coverage, the company stated.